Archive.fm

Biotech 2050 Podcast

108. Vibe Bio launches to transform drug development, Alok Tayi Ph.D. and Susanna Harris Ph.D.

Our guest this week is one of our hosts, Alok Tayi, and he has some exciting news. The official launch of his new company, Vibe Biotechnology, building a global community of patients, scientists, and partners around a shared mission to cure rare diseases. Vibe Bio's novel approach seeks to scale the development of treatments sustainably and provides patient communities unprecedented ownership over the results.

Alok is a scientist by trade, with over 15 years under his belt including a PhD at Northwestern - and time spent at Harvard under a successful biotech founder. He then went on to start multiple biotech software companies - securing over $100M in total venture funding along the way.

Through his own personal and professional experience, Alok has realized that the families of patients with rare diseases have plenty of hope - but what they need is help. Not necessarily finding the right potential therapeutic option - but actually funding it. That’s where the Vibe community steps in - vetting out which drug development programs have the highest potential and financing the process via crypto token sales.

Tapping into the crypto market opens up a wealth of new opportunities when it comes to tackling some of these major rare diseases. Vibe’s aim is to give families not only the community of support - but the genuine power to pursue a cure for any rare disease at scale - an issue that impacts 1 in 10 Americans.

Sit back, relax, and we hope you enjoy this enlightening conversation between Alok and our wonderful guest host Susanna Harris, PhD.

Broadcast on:
22 Jun 2022